Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Thompson

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Journal of Musculoskeletal & Neuronal Interactions|March 11, 2005
Alfacalcidol restores cancellous bone in ovariectomized ratsM Li, D R Healy, H A Simmons, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 24, 2001
Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male ratsH Z Ke, H Qi, K L Chidsey-Frink, et al.
The American Journal of Cardiology|August 1, 1997
Persistence of human leukocyte antigen (HLA) antibodies after one year in children receiving cryopreserved valved allograftsR E Shaddy, D D Thompson, K A Osborne, et al.
Chronobiologia|April 1, 1981
Circadian heart rate rhythmicity: comparison between an Eskimo and other population groupsJ Clench, S A Barton, W J Schull, et al.
Endocrinology|June 1, 1995
Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized ratsH Z Ke, H A Simmons, C M Pirie, et al.
Endocrinology|April 4, 2000
Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult ratH Z Ke, H Qi, D T Crawford, et al.
The Journal of Clinical Investigation|December 1, 1991
Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructureM Sato, W Grasser, N Endo, et al.
Endocrinology|September 1, 1994
Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood plateletsM A Thiede, S L Smock, D N Petersen, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 27, 2007
Effects of gestational age on prostaglandin EP receptor expression and functional involvement during in vitro contraction of the guinea pig uterusK K Terry, W S Lebel, K A Riccardi, et al.
Pediatrics|July 4, 1998
A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsisK R Schibler, K A Osborne, L Y Leung, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Journal of Musculoskeletal & Neuronal Interactions|March 11, 2005
Alfacalcidol restores cancellous bone in ovariectomized ratsM Li, D R Healy, H A Simmons, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 24, 2001
Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male ratsH Z Ke, H Qi, K L Chidsey-Frink, et al.
The American Journal of Cardiology|August 1, 1997
Persistence of human leukocyte antigen (HLA) antibodies after one year in children receiving cryopreserved valved allograftsR E Shaddy, D D Thompson, K A Osborne, et al.
Chronobiologia|April 1, 1981
Circadian heart rate rhythmicity: comparison between an Eskimo and other population groupsJ Clench, S A Barton, W J Schull, et al.
Endocrinology|June 1, 1995
Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized ratsH Z Ke, H A Simmons, C M Pirie, et al.
Endocrinology|April 4, 2000
Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult ratH Z Ke, H Qi, D T Crawford, et al.
The Journal of Clinical Investigation|December 1, 1991
Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructureM Sato, W Grasser, N Endo, et al.
Endocrinology|September 1, 1994
Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood plateletsM A Thiede, S L Smock, D N Petersen, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 27, 2007
Effects of gestational age on prostaglandin EP receptor expression and functional involvement during in vitro contraction of the guinea pig uterusK K Terry, W S Lebel, K A Riccardi, et al.
Pediatrics|July 4, 1998
A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsisK R Schibler, K A Osborne, L Y Leung, et al.
Pageof 8